Cellumed Co., Ltd. and Shim Young-Bok completed the acquisition of 3.55% stake in Mgenplus Co., Ltd. from Yong-Hyun Shin.
September 09, 2015
Share
Cellumed Co., Ltd. (KOSDAQ:A049180) and Shim Young-Bok agreed to acquire 3.55% stake in Mgenplus Co., Ltd. (KOSDAQ:A032790) from Yong-Hyun Shin for KRW 5 billion in cash on August 18, 2015. Cellumed will acquire 0.21 million shares for KRW 3.5 billion and Shim Young-Bok will acquire 0.09 million shares for KRW 1.5 billion. Cellumed paid the deposit of KRW 3 billion on August 18, 2015 and will pay the remaining balance of KRW 500 million on October 1, 2015. Shim Young-Bok will pay the balance of KRW 1.5 billion on October 1, 2015. In a related transaction, Cellumed Co., Ltd will purchase 0.7 million new shares of Mgenplus through capital increase. The board of Cellumed passed a resolution for the transaction on August 18, 2015. The transaction is expected to close on October 1, 2015.
Cellumed Co., Ltd. (KOSDAQ:A049180) and Shim Young-Bok completed the acquisition of 3.55% stake in Mgenplus Co., Ltd. (KOSDAQ:A032790) from Yong-Hyun Shin on September 10, 2015.
Mgen Solutions Co Ltd, formerly BNGT Co Ltd, is a Korea-based company engaged in the manufacture and sale of printer cartridge parts. The Company operates its business through five segments. The Developing Machine Business segment is engaged in the manufacture and sale of printer cartridge parts. The Broadband Convergence Network (BcN)/Artificial Intelligence (AI) Business segment is engaged in the operation and build of broadband self-communication network. The Segment is also engaged in the provision of artificial intelligence image analysis solutions. The Communication Network Business segment is engaged in the provision of information technology services related to smart homes and the Internet of Things (IoT). The Bio Business segment is engaged in the development of organs for transplantation. The Other Business segment is engaged in the sale of medical devices.